MKI67 and breast carcinoma: Moreover, high CD8 expression was associated with shorter DFS in PR-negative, HER-2-positive, and high Ki-67 L.I. (Ki-67 L.I. > 14) breast cancers (p = 0.022, p = 0.001, and p = 0.005, respectively; Figure 3D–F).